Klaus Orlinger

Insider Reports History

Location
New York, NY
Signature
/s/ Reinhard Kandera, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Klaus Orlinger:

Company Role Class Num Shares Value Price $ Report Date Ownership
HOOKIPA Pharma Inc. Chief Scientific Officer Stock Option (Right to Buy) 367,300 $1,101,900 $3.00 15 Apr 2024 Direct

Insider Reports Filed by Klaus Orlinger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HOOK HOOKIPA Pharma Inc. 15 Apr 2024 1 $0 4 Chief Scientific Officer 17 Apr 2024, 16:15
HOOK HOOKIPA Pharma Inc. 14 Apr 2023 1 $0 4 Chief Scientific Officer 18 Apr 2023, 19:50
HOOK HOOKIPA Pharma Inc. 30 Jun 2022 1 $0 4 Chief Scientific Officer 01 Jul 2022, 16:13
HOOK HOOKIPA Pharma Inc. 19 Apr 2022 1 $0 4 Chief Scientific Officer 20 Apr 2022, 16:30
HOOK HOOKIPA Pharma Inc. 01 Feb 2022 2 +$65,526 4 Executive VP, Research 01 Feb 2022, 19:52